Oral-health quality of life and treatment patterns in people with new dentin hypersensitivity
A Longitudinal Study Evaluating Oral-Health-Related Quality of Life and Treatment Patterns Among Dentin Hypersensitivity Sufferers in the Real World
This study will test whether monthly online questionnaires over a year can track changes in oral-health-related quality of life and treatment use in adults who recently began having dentin hypersensitivity.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 375 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Haleon Industry-sponsored |
| Locations | 1 site (Las Vegas, Nevada) |
| Trial ID | NCT07337109 on ClinicalTrials.gov |
What this trial studies
This is a 12-month longitudinal observational study enrolling 375 adults in the United States who self-report new-onset dentin hypersensitivity within the past three months. Participants will complete a monthly online battery including the Dentin Hypersensitivity Experience Questionnaire (DHEQ) to measure oral-health-related quality of life and report treatments they use. No experimental interventions are given; the study records treatment patterns and symptom trajectories in a real-world setting. Data will be used to describe how quality of life changes over time and which consumer or clinical products are adopted.
Who should consider this trial
Good fit: Adults (≥18) living in the United States who self-identify as having started experiencing dentin hypersensitivity within the past three months, who have begun using sensitivity treatments within the past three months, and who can complete monthly online surveys are ideal candidates.
Not a fit: People with chronic health conditions that affect participation, those whose tooth sensitivity is due to other dental pathologies, those with longstanding sensitivity (>3 months), or those living outside the United States are unlikely to benefit.
Why it matters
Potential benefit: If successful, findings could help dentists, manufacturers, and patients understand how sensitivity affects daily life and which common treatments actually correlate with improved quality of life.
How similar studies have performed: Previous observational work using patient-reported measures like the DHEQ has described the burden of dentin hypersensitivity, although monthly longitudinal tracking over a full year is less common.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participant who has provided consent indicating they have been informed of all pertinent aspects of the study. * All genders who, at the time of screening, are aged more than or equal to (\>=)18 years. * Anyone who has begun to experience dentin hypersensitivity (self-reported) within the past three months. * Anyone who has started to use products to treat their tooth sensitivity within the past three months. * Participant who is able to independently complete all activities online. * Participants residing in the United States. Exclusion Criteria: * Anyone who has any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period. * Participant whose sensitivity could be caused by other factors or clinical pathology than DH, as self-reported on the screening questionnaire, which include: 1. Anyone who suffers from tooth cavities, significant gum disease, cracked or fractured teeth, temporomandibular joint disease (TMD), or who has had tooth extractions or fillings within the last three months. 2. Anyone who wears braces (including Invisalign-like appliances) for treatment or dentures (full or partial). 3. Participant who has undergone treatment for periodontal or gum disease within 6 months of screening or is currently undergoing treatment for periodontal or gum disease. 4. Participant who has been informed by a Dental Health Care Professional (DHCP) that they have active periodontitis. 5. Participant who has been informed by a DHCP that they have active caries. 6. Participant with any chronic and/or severe painful health condition(s) which lead to regular use of pain relief medications (more than 3 days a week). * Anyone who has participated in another dentin hypersensitivity study within the last three months. * Currently participating in another research study or will be participating in any other research study at any point during this study's duration.
Where this trial is running
Las Vegas, Nevada
- Citruslabs (Virtual Site) — Las Vegas, Nevada, United States (Recruiting)
Study contacts
- Study coordinator: Haleon Response Center
- Email: ww.clinical-trial-register@haleon.com
- Phone: +441932959500
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.